<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04421326</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL18_0236</org_study_id>
    <nct_id>NCT04421326</nct_id>
  </id_info>
  <brief_title>Multimodal Investigation of Intracranial Clot Environment</brief_title>
  <acronym>MISO</acronym>
  <official_title>Multimodal Investigation of Intracranial Clot Environment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Genomic Institute of Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analysis of peri clot blood collected at the acute phase of stroke in order to understand
      physiopathological mechanisms involved in the cerebrovascular damage
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It has been shown that immune cells accumulate around the clot at the acute phase of stroke.
      Leukocytes and their specific chemokines and cytokines regulation may impact cerebrovascular
      integrity.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">October 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Metalloproteinase 9 quantification</measure>
    <time_frame>60 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Metalloproteinase 2 quantification</measure>
    <time_frame>60 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cytokines levels</measure>
    <time_frame>60 months</time_frame>
    <description>Proteomic analysis of cytokines IL-1β, TNF-α, IL-6</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Ichemic Stroke</condition>
  <condition>Brain Ischemia</condition>
  <arm_group>
    <arm_group_label>Patients with acute ischemic stroke</arm_group_label>
    <description>Patients undergoing Mechanical Thrombectomy for large vessel occclusion with acute ischemic stroke</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Analysis of the clot</intervention_name>
    <description>Blood sampling at the site of intracranial occlusion during Mechanical Thrombectomy</description>
    <arm_group_label>Patients with acute ischemic stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing Mechanical Thrombectomy for large vessel occclusion with acute ischemic
        stroke
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Over 18 years of age,

          2. Non-dependent for activities of daily living prior to the onset of the MI (Modified
             Rankin Score &gt;2)

          3. Having an occlusion of a large arterial trunk proven by imaging (angio-MRI or
             angio-scanner).

        Exclusion criteria:

          1. Patients initially admitted but for whom endovascular treatment will not finally be
             performed (re-infusion, catheterization failure...) will be excluded from the study.

          2. Major patients under guardianship or curatorship or patients deprived of liberty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent COSTALAT, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montpellier University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cyril DARGAZANLI, MD MSc</last_name>
    <phone>467337532</phone>
    <phone_ext>+33</phone_ext>
    <email>c-dargazanli@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincent COSTALAT, MD PhD</last_name>
    <phone>467337532</phone>
    <phone_ext>+33</phone_ext>
    <email>v-costalat@chu-montpellier.fr</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 28, 2020</study_first_submitted>
  <study_first_submitted_qc>June 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Blood Brain Barrier</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Thrombus</keyword>
  <keyword>Interventional Neuroradiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

